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Table S1.  Number of Type 1 and Type 2 Diabetes Cases By Incidence Year (two-year moving averages): SEARCH for Diabetes in Youth 
 Type 1 Diabetes Cases 
 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 
All   938.5 916.0 957.0 1,009.5 1,051.5 1,091.0 1,101.5 1,027.5 1,035.0 1,097.0 
Age at Diagnosis (years)           
  0-4 188.0 183.5 167.5 169.0 168.5 170.0 177.5 169.0 172.0 175.0 
  5-9 278.5 273.5 300.0 318.0 343.0 362.0 362.0 339.0 335.5 349.5 
  10-14 337.5 339.0 358.0 376.0 379.0 395.0 397.0 361.0 369.0 405.0 
  15-19 134.5 120.0 131.5 146.5 161.0 164.0 165.0 158.5 158.5 167.5 
Sex           
  Girls 450.5 448.5 454.5 469.5 498.5 524.5 529.0 486.5 482.0 493.5 
  Boys 488.0 467.5 502.5 540.0 553.0 566.5 572.5 541.0 553.0 603.5 
Race/Ethnicity           
  NHW 694.3 675.3 691.7 719.8 749.3 780.3 784.2 721.5 714.1 759.1 
  NHB 104.6 113.0 121.9 115.1 117.2 128.4 119.7 112.4 126.5 136.8 
  Hispanic 112.4 103.0 121.4 147.0 156.6 158.9 171.8 170.7 164.7 162.9 
  API 18.5 17.3 17.1 21.6 22.1 17.8 19.4 16.1 22.6 30.3 
  AI 8.7 7.4 5.1 6.0 6.3 5.5 6.4 6.8 7.1 7.9 
Site           
  SC 192.0 190.5 204.0 205.0 223.0 245.5 242.0 232.5 231.0 225.0 
  OH 136.0 149.5 138.0 129.0 132.0 135.5 134.5 139.5 142.5 143.0 
  CO 287.0 267.0 279.0 304.5 328.5 344.0 357.0 319.5 308.0 343.5 
  CA 115.0 107.5 127.5 142.0 138.5 130.5 133.0 136.0 133.5 138.0 
  WA 208.5 201.5 208.5 229.0 229.5 235.5 235.0 200.0 220.0 247.5 
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 Type 2 Diabetes Cases 
All   225.5 209.5 205.0 207.0 231.0 256.0 282.0 312.0 321.5 321.5 
Age at diagnosis (years)            
  10-14 102.5 93.0 101.0 100.0 107.0 120.5 137.0 149.0 154.5 154.0 
  15-19 123.0 116.5 104.0 107.0 124.0 135.5 145.0 163.0 167.0 167.5 
Sex           
  Girls 136.0 119.0 113.5 121.0 142.0 155.0 170.5 197.5 200.5 203.5 
  Boys 89.5 90.5 91.5 86.0 89.0 101.0 111.5 114.5 121.0 118.0 
Race/Ethnicity           
  NHW 67.1 61.7 52.0 47.4 46.4 58.9 66.6 70.9 65.9 56.1 
  NHB 75.5 73.3 73.8 72.1 84.7 91.9 99.3 114.6 116.6 118.8 
  Hispanic 53.6 52.3 58.6 64.9 76.8 78.3 81.7 85.3 93.7 98.6 
  API 13.4 9.9 7.1 5.3 7.4 10.0 12.7 19.3 20.4 19.1 
  AI 15.8 12.2 13.6 17.2 15.7 17.0 21.6 21.9 24.8 28.8 
Site           
  SC 59.5 64.0 58.5 53.0 64.5 80.0 93.0 103.5 102.5 102.0 
  OH 33.5 26.5 26.5 25.5 26.0 26.5 26.5 24.0 22.0 27.0 
  CO  40.5 36.5 41.0 47.0 41.5 41.0 49.5 55.5 57.5 60.0 
  CA 61.0 56.0 62.5 67.5 79.5 75.5 76.5 85.5 86.0 88.5 
  WA 31.0 26.5 16.5 14.0 19.5 33.0 36.5 43.5 53.5 44.0 






Table S2.  Denominators*for Estimation of Incidence of Type 1 Diabetes – Moving Averages  (age 0-19) (counts in thousands) 
 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 
All   4,807.1 4,798.7 4,813.7 4,863.5 4,916.0 4,956.1 5,002.2 5,034.2 5,051.1 5,058.9 
Age at diagnosis years)            
  0-4 1,137.2 1,139.0 1,146.4 1,160.9 1,180.7 1,200.6 1,216.5 1,223.9 1,226.3 1,223.1 
  5-9 1,162.0 1,147.4 1,147.1 1,163.2 1,182.5 1,197.1 1,216.7 1,234.1 1,245.8 1,260.1 
  10-14 1,279.7 1,273.3 1,261.6 1,254.0 1,248.2 1,242.0 1,245.3 1,255.2 1,266.6 1,275.0 
  15-19 1,228.2 1,239.0 1,258.6 1,285.4 1,304.6 1,316.4 1,323.7 1,320.9 1,312.4 1,300.7 
Sex           
  Girls 2,347.5 2,344.2 2,352.2 2,377.3 2,403.9 2,424.8 2,448.1 2,463.9 2,471.9 2,474.8 
  Boys 2,459.6 2,454.5 2,461.5 2,486.2 2,512.1 2,531.3 2,554.0 2,570.3 2,579.2 2,584.1 
Race/Ethnicity           
  NHW 2,904.9 2,878.2 2,858.8 2,854.5 2,851.3 2,848.3 2,848.6 2,835.1 2,817.3 2,806.5 
  NHB 714.3 711.3 709.8 713.1 718.0 721.8 725.8 726.2 722.9 719.7 
  Hispanic 822.0 842.5 873.7 914.3 956.1 987.6 1,018.0 1,052.1 1,082.0 1,099.8 
  API 235.3 237.7 242.8 253.2 263.6 271.8 280.8 293.8 305.2 311.1 
  AI 130.6 129.0 128.7 128.4 127.0 126.6 129.0 127.0 123.6 121.8 
Site           
  SC 1,139.5 1,147.5 1,155.0 1,167.1 1,184.3 1,201.3 1,213.7 1,219.1 1,215.6 1,210.4 
  OH 551.6 552.4 553.1 553.8 555.2 556.1 556.2 554.8 551.5 548.3 
  CO  1,367.5 1,371.0 1,377.6 1,390.7 1,406.1 1,423.4 1,442.6 1,452.9 1,456.6 1,458.9 
  CA  793.7 772.6 770.7 788.8 797.9 793.4 796.5 808.3 828.1 840.4 
  WA 954.7 955.2 957.3 963.1 972.5 981.9 993.1 999.1 999.2 1,000.8 
*Counts presented are the average of the number at risk in the given year and the preceding year.  Denominators were determined as: SC, OH, CO, WA from US Census data; CA 
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Table S3.  Denominators* for Estimation of Incidence of Type 2 Diabetes – Moving Averages (counts in thousands) 
 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 
All   2,508.0 2,512.3 2,520.2 2,539.4 2,552.8 2,558.4 2,569.0 2,576.1 2,579.0 2,575.7 
Age at diagnosis (years)            
  10-14 1,279.7 1,273.3 1,261.6 1,254.0 1,248.2 1,242.0 1,245.3 1,255.2 1,266.6 1,275.0 
  15-19 1,228.2 1,239.0 1,258.6 1,285.4 1,304.6 1,316.4 1,323.7 1,320.9 1,312.4 1,300.7 
Sex           
  Girls 1,224.6 1,227.4 1,231.9 1,241.2 1,247.7 1,250.9 1,256.5 1,260.3 1,261.6 1,259.7 
  Boys 1,283.3 1,284.9 1,288.2 1,298.2 1,305.1 1,307.5 1,312.5 1,315.8 1,317.3 1,316.0 
Race/Ethnicity           
  NHW 1,536.5 1,527.0 1,516.5 1,511.4 1,503.5 1,494.3 1,487.7 1,475.1 1,461.7 1,451.8 
  NHB 377.0 378.8 379.5 380.3 379.6 377.7 376.1 373.1 369.1 364.7 
  Hispanic 402.8 414.2 429.6 448.3 466.6 479.9 494.1 512.7 530.3 540.8 
  API 121.7 122.8 125.2 130.4 135.5 139.3 143.4 149.1 154.1 156.5 
  AI 70.0 69.6 69.5 68.9 67.7 67.2 67.8 66.1 63.7 62.0 
Site           
  SC 594.5 601.2 604.5 608.9 613.8 617.4 620.2 621.8 618.8 613.9 
  OH 283.3 284.0 284.1 284.2 283.8 282.8 281.9 280.4 278.6 277.3 
  CO  698.9 700.4 701.8 704.3 706.4 710.0 715.6 717.9 719.7 722.5 
  CA  438.0 431.2 433.2 444.1 448.9 446.6 447.6 453.4 463.7 468.4 
 WA 493.2 495.5 496.5 497.9 499.8 501.6 503.7 502.6 498.2 493.6 
*Counts presented are the average of the number at risk in the given year and the preceding year.  Denominators were determined as: 




Table S4  Type 1 Diabetes Incidence Rates Per 100,000/Year Using Two-Year Moving Averages Unadjusted Models Adjusted Models*** 
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* {q49}Rates were based on the number of cases and the number at risk in the given year and the preceding year (2-year moving average). P values are from a generalized autoregressive 
moving average (GARMA) linear model unless otherwise noted. The 95% confidence intervals for the yearly data are provided in Table S4 in the Supplementary Appendix. CI denotes 
confidence interval. 
† The analysis was adjusted for age, sex, and race or ethnic group (age was adjusted for sex and race or ethnic group; sex was adjusted for age and race or ethnic group; race or ethnic 
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group was adjusted for age and sex; and study site was adjusted for age, sex, and race or ethnic group). 
‡ P values are from linear negative binomial model, because the GARMA model was unable to estimate them. 
 
 
Table S5. Type 2 Diabetes Incidence Rates (Per 100,000/Year) Using Two-Year Moving Averages Unadjusted Models Adjusted Models*** 
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* Rates were based on the number of cases and the number at risk in the given year and the preceding year (2-year moving average). P values are from the GARMA linear model unless 
otherwise noted. The 95% confidence intervals for the yearly data are provided in Table S5 in the Supplementary Appendix.   
† The analysis was adjusted for age, sex, and race or ethnic group (age was adjusted for sex and race or ethnic group; sex was adjusted for age and race or ethnic group; race or ethnic 
group was adjusted for age and sex; and study site was adjusted for age, sex, and race or ethnic group). 
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‡ P values are from linear negative binomial model, because the GARMA model was unable to estimate them. 
 
